These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19139477)
1. Anticoagulation in patients with heart failure and normal sinus rhythm. Ripley TL; Nutescu E Am J Health Syst Pharm; 2009 Jan; 66(2):134-41. PubMed ID: 19139477 [TBL] [Abstract][Full Text] [Related]
2. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; MarĂn F; Lane DA; Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation Therapy and NOACs in Heart Failure. Thomas I; EncisoSilva J; Schlueter M; Greenberg B Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice. Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188 [TBL] [Abstract][Full Text] [Related]
5. A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis. Sulaica EM; Macaulay TE; Helbing RR; Abo-Aly M; Abdel-Latif A; Wanat MA Heart Fail Rev; 2020 Mar; 25(2):207-216. PubMed ID: 31256317 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy for heart failure in sinus rhythm. Subramaniam V; Davis RC; Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation versus placebo for heart failure in sinus rhythm. Lip GY; Wrigley BJ; Pisters R Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335 [TBL] [Abstract][Full Text] [Related]
8. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA; Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal. Prom R; Usedom JE; Dull RB Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation in Patients with Heart Failure and Sinus Rhythm. Li X; Yang J; Xu D Int Heart J; 2020 Nov; 61(6):1204-1211. PubMed ID: 33191346 [TBL] [Abstract][Full Text] [Related]
11. Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm. Hopper I; Skiba M; Krum H Eur J Heart Fail; 2013 Jan; 15(1):69-78. PubMed ID: 23143796 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Lip GY; Gibbs CR Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189 [TBL] [Abstract][Full Text] [Related]
13. Dilated cardiomyopathy and role of antithrombotic therapy. Abdo AS; Kemp R; Barham J; Geraci SA Am J Med Sci; 2010 Jun; 339(6):557-60. PubMed ID: 20186041 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials. Liew AY; Eikelboom JW; Connolly SJ; O' Donnell M; Hart RG Int J Stroke; 2014 Feb; 9(2):199-206. PubMed ID: 23506160 [TBL] [Abstract][Full Text] [Related]
15. Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification? Rivas A; Lauw MN; Schnabel RB; Crowther M; Van Spall HGC Thromb Haemost; 2022 Jun; 122(6):871-878. PubMed ID: 35045579 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. Lip GY; Gibbs CR QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150 [TBL] [Abstract][Full Text] [Related]
17. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425 [TBL] [Abstract][Full Text] [Related]
18. What do we know about anticoagulation in patients with heart failure? Ahnert AM; Freudenberger RS Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. Gurbel PA; Tantry US JACC Heart Fail; 2014 Feb; 2(1):1-14. PubMed ID: 24622113 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic Therapy for Heart Failure in Sinus Rhythm - A Concise Review. Sharma R; Subedi A S D Med; 2024 May; 77(5):213-219. PubMed ID: 39012774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]